CDH5 and COVID-19: Meanwhile, studies have found that RAP1 can enhance endothelial cell–cell junctions mediated by VE-cadherin and regulate vascular permeability (Rho et al., 2017), suggesting that the RAP1 signaling pathway may serve as a potential therapeutic target for COVID-19.